Analysts think CTXR stock price could increase by 222%
Feb 16, 2025, 12:25 PM
-43.49%
What does CTXR do
Citius Pharmaceuticals, based in Cranford, NJ, specializes in critical care products, particularly in oncology and anti-infectives. Its key products include LYMPHIR, Mino-Lok, Halo-Lido, Mino-Wrap, and NoveCite.
4 analysts think CTXR stock price will increase by 222.30%. The current median analyst target is $8.67 compared to a current stock price of $2.69. The lowest analysts target is $8.08 and the highest analyst target is $9.45.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
